Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 3/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.55 |
| ▸ | CDC25A | P30304 | 2/20 | 0.54 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.53 |
| ▸ | POLA1 | P09884 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4734954 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4734844 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4734841 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4734953 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4735795 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4782232 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4782228 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4737064 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4740092 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 | |
| SCHEMBL4737067 | 1.00 | VDR (0.59) | VDRUSP2ST6GAL1CDC25AABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. | 2022-04-21 | — | — | US | disclosed |
| EP-3973972-A1 | MULTI-SUPPLEMENT COMPOSITIONS | Melaleuca, Inc. (US) | 2022-03-30 | — | — | EP | disclosed |
| US-11207388-B2 | Multi-supplement compositions | MELALEUCA, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| EP-3240555-B1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA INC (US) | 2021-08-04 | — | — | EP | disclosed |
| EP-3240555-A1 | MULTI-SUPPLEMENT COMPOSITIONS | Melaleuca, Inc. (US) | 2017-11-08 | — | — | EP | disclosed |
| US-20170209463-A1 | DIETARY SUPPLEMENT COMPOSITIONS FOR CARDIOVASCULAR HEALTH | MELALEUCA, INC. | 2017-07-27 | — | — | US | disclosed |
| US-20160193306-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. | 2016-07-07 | — | — | US | disclosed |
| WO-2016109856-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. (US) | 2016-07-07 | — | — | WO | disclosed |
| US-20110038848-A1 | DIETARY SUPPLEMENT COMPOSITIONS FOR CARDIOVASCULAR HEALTH | MELALEUCA, INC. (US) | 2011-02-17 | — | — | US | disclosed |
| WO-2007024770-A2 | METHODS OF FORMING PHYTOSTEROL-FORTIFIED COCOA POWDER AND THE PRODUCT FORMED THEREFROM | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2007-03-01 | — | — | WO | disclosed |
| US-20070042102-A1 | Methods of forming phytosterol-fortified cocoa powder and the product formed therefrom | ARCHER -DANIELS- MIDLAND COMPANY | 2007-02-22 | — | — | US | disclosed |
| US-20050032757-A1 | Nutritional supplements | MELALEUCA, INC. | 2005-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170209463-A1 | DIETARY SUPPLEMENT COMPOSITIONS FOR CARDIOVASCULAR HEALTH | APOB, FABP3, HDLBP | VDR 67/4885USP2 905/4885ST6GAL1 2680/4885 |
| US-11207388-B2 | Multi-supplement compositions | SLC5A6, FABP2, GLS2 | VDR 42/4885USP2 2501/4885ST6GAL1 2348/4885 |
| US-20050032757-A1 | Nutritional supplements | SREBF1, SREBF2, CETP | VDR 61/4885USP2 3718/4885ST6GAL1 917/4885 |
| US-20160193306-A1 | MULTI-SUPPLEMENT COMPOSITIONS | SLC5A6, FABP2, GLS2 | VDR 42/4885USP2 2501/4885ST6GAL1 2348/4885 |
| US-20110038848-A1 | DIETARY SUPPLEMENT COMPOSITIONS FOR CARDIOVASCULAR HEALTH | APOB, FABP3, HDLBP | VDR 67/4885USP2 905/4885ST6GAL1 2680/4885 |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | SLC5A6, FABP2, GLS2 | VDR 42/4885USP2 2501/4885ST6GAL1 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.